In this paper, we concentrated on the docking approach to analyse effective treatment for cancer. Docking studies have been performed on the novel pyrazolo [3,4-d] pyrimidines to explore the structural features responsible for their activity on EGFR kinases. Series of pyrazolo [3,4-d] pyrimidine derivatives compounds were taken from M M Kandeel et al., for anti-tumor activity. SYBYL - X 2.0 software were used for docking. From the docking studies we got 3 best docked compounds.
Loading....